Clinical Trial Update: AT13387 in Adults With Refractory Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of AT13387 in adults with refractory solid tumors, including breast cancer, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumors

Drugs mentioned

• AT13387 (AT13387)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Solid Tumors, Breast Cancer | Phase 1 | Status: COMPLETED